The hormonal mechanism of the effects of meperidine, sertraline, tianeptine, and their combinations on reproductive functions in female rats

ArticleAçık Erişim

Özet

Background: Infertility caused by drugs that inhibit serotonin reuptake has been attributed to serotonin toxicity. Serotonin has been linked to cause a rise in prolactin and cortisol. This study examined the effects of meperidine, sertraline, tianeptine and combinations on female rat reproductive function. Methods: Female rats were split into 8 groups (n=7): healthy control (HG), meperidine (MG), sertraline (SG), tianeptine (TG), meperidine+sertraline (MSG), meperidine+tianeptine (MTG), sertraline+tianeptine (STG), meperidine+sertraline+tianeptine (MSTG). Meperidine (20 mg/kg, 2×1) was injected intramuscularly. Sertraline (30 mg/kg, 1×1) and tianeptine (5 mg/kg, 1×1) were given orally. The HG received distilled water as solvent. Treatments continued for 20 days. Then, adult males were added to the rat groups and drug treatment continued for another five days. Blood samples were collected on day 26 for biochemical tests. Results: Total oxidant status (TOS) and total antioxidant status (TAS) were not statistically significant between groups (p>0.05). Meperidine (p<0.001) and sertraline (p<0.001) alone increased prolactin levels in comparison to HG and tianeptine inhibited the increase (p<0.001). While meperidine increased corticosterone levels versus HG (p<0.001), sertraline and tianeptine were close to HG (p>0.05). Number of infertile animals was 6 for meperidine, 3 for sertraline, and none for tianeptine. While the duration of pregnancy in MG (15 days) and SG (15 days) was longer compared to HG (2.86 days), no change was observed in TG (2.5 days). Conclusion: Tianeptine and other serotonin re-uptake stimulants may be useful in the treatment of reproductive dysfunction and infertility due to serotonin re-uptake inhibitor treatment. © 2024 The Authors

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11207Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorYilmaz, Betul Kalkan
dc.contributor.authorSuleyman, Zeynep
dc.contributor.authorSuleyman, Bahadır
dc.contributor.authorMammadov, Renad
dc.contributor.authorBulut, Seval
dc.contributor.authorAltuner, Durdu
dc.contributor.authorAlptekin, Okay
dc.contributor.authorCoban, Taha Abdulkadir
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:26:17.509496878Z
dc.date.available2026-10-18T20:26:17.509496878Z
dc.date.issued2024
dc.description.abstractBackground: Infertility caused by drugs that inhibit serotonin reuptake has been attributed to serotonin toxicity. Serotonin has been linked to cause a rise in prolactin and cortisol. This study examined the effects of meperidine, sertraline, tianeptine and combinations on female rat reproductive function. Methods: Female rats were split into 8 groups (n=7): healthy control (HG), meperidine (MG), sertraline (SG), tianeptine (TG), meperidine+sertraline (MSG), meperidine+tianeptine (MTG), sertraline+tianeptine (STG), meperidine+sertraline+tianeptine (MSTG). Meperidine (20 mg/kg, 2×1) was injected intramuscularly. Sertraline (30 mg/kg, 1×1) and tianeptine (5 mg/kg, 1×1) were given orally. The HG received distilled water as solvent. Treatments continued for 20 days. Then, adult males were added to the rat groups and drug treatment continued for another five days. Blood samples were collected on day 26 for biochemical tests. Results: Total oxidant status (TOS) and total antioxidant status (TAS) were not statistically significant between groups (p>0.05). Meperidine (p<0.001) and sertraline (p<0.001) alone increased prolactin levels in comparison to HG and tianeptine inhibited the increase (p<0.001). While meperidine increased corticosterone levels versus HG (p<0.001), sertraline and tianeptine were close to HG (p>0.05). Number of infertile animals was 6 for meperidine, 3 for sertraline, and none for tianeptine. While the duration of pregnancy in MG (15 days) and SG (15 days) was longer compared to HG (2.86 days), no change was observed in TG (2.5 days). Conclusion: Tianeptine and other serotonin re-uptake stimulants may be useful in the treatment of reproductive dysfunction and infertility due to serotonin re-uptake inhibitor treatment. © 2024 The Authors
dc.identifier.doi10.1016/j.biopha.2024.117160
dc.identifier.eissn1950-6007
dc.identifier.issn0753-3322
dc.identifier.pmid39029404
dc.identifier.scopus2-s2.0-85198954899
dc.identifier.startpage117160
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11207
dc.identifier.volume178
dc.identifier.wosWOS:001282185400001
dc.language.isoen
dc.publisherElsevier Masson s.r.l.
dc.relation.ispartofBiomedicine and Pharmacotherapy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCorticosterone
dc.subjectMeperidine
dc.subjectProlactin
dc.subjectSertraline
dc.subjectTianeptine
dc.subjectAnimals
dc.subjectAntioxidants
dc.subjectFemale
dc.subjectMale
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectReproduction
dc.subjectSelective Serotonin Reuptake Inhibitors
dc.subjectThiazepines
dc.subjectantioxidant
dc.subjectdistilled water
dc.subjecthydrocortisone
dc.subjectoxidizing agent
dc.subjectpethidine
dc.subjectserotonin uptake inhibitor
dc.subjectthiazepine derivative
dc.subjectadult
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectArticle
dc.subjectbiochemical analysis
dc.subjectblood sampling
dc.subjectcontrolled study
dc.subjectcorticosterone blood level
dc.subjecthormone action
dc.titleThe hormonal mechanism of the effects of meperidine, sertraline, tianeptine, and their combinations on reproductive functions in female rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus5
rdl.citation.wos4
rdl.departmentDepartment of Gynecology and Obstetric, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: betul.yilmaz@erzincan.edu.tr. | Department of Nursing, Faculty of Health Sciences, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: zsuleyman@erzincan.edu.tr. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: bsuleyman@erzincan.edu.tr. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: rmammadov@erzincan.edu.tr. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: seval.bulut@erzincan.edu.tr. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: daltuner@erzincan.edu.tr. | Department of Gynecology and Obstetric, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: okayalptekin@saglik.gov.tr. | Department of Medical Biochemistry, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: acoban@erzincan.edu.tr. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan 24100, Turkey. Electronic address: hsuleyman@erzincan.edu.tr.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)